Skip to content

Immuneering Corporation: 10-Q filed 2022-11-10

What Immuneering Corporation reported in its quarterly report filed 2022-11-10 (fiscal Q3 2022): 47 published measures, 134 facts as tagged in accession 0001558370-22-017304.

This filing

Form
10-Q (quarterly report)
Filed
2022-11-10
Fiscal period
fiscal Q3 2022
Accession
0001558370-22-017304 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Immuneering Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-09-30133,691,627USD
At 2021-12-31166,704,832USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-09-3011,798,425USD
At 2021-12-3110,724,723USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-09-30121,893,202USD
At 2022-06-30133,594,846USD
At 2022-03-31144,056,110USD
At 2021-12-31155,980,109USD
At 2021-09-30158,293,625USD
At 2021-06-30-35,185,780USD
At 2021-03-31-28,528,876USD
At 2020-12-31-22,481,450USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-09-3076,417,850USD
At 2021-12-3174,888,145USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-12,844,330USD92
2022-01-01 to 2022-09-30-37,268,007USD273
2022-04-01 to 2022-06-30-11,527,303USD91
2022-01-01 to 2022-03-31-12,896,374USD90
2021-07-01 to 2021-09-30-8,534,073USD92
2021-01-01 to 2021-09-30-22,751,389USD273
2021-04-01 to 2021-06-30-7,987,665USD91
2021-01-01 to 2021-03-31-6,229,651USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-32,352,651USD273
2021-01-01 to 2021-09-30-21,611,892USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-09-30673,181USD273
2021-01-01 to 2021-09-3047,734USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-07-01 to 2022-09-3038,380USD92
2022-01-01 to 2022-09-30316,497USD273
2021-07-01 to 2021-09-30482,130USD92
2021-01-01 to 2021-09-301,890,370USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-09-30203,681USD273
2021-01-01 to 2021-09-30144,257,324USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-09-3033,678,675USD273
2021-01-01 to 2021-09-30-52,808,033USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-09-30-96,541,395USD
At 2021-12-31-59,273,388USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-07-01 to 2022-09-3026,394,490shares92
2022-01-01 to 2022-09-3026,380,101shares273
2021-07-01 to 2021-09-3018,286,352shares92
2021-01-01 to 2021-09-309,445,862shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-07-01 to 2022-09-3026,394,490shares92
2022-01-01 to 2022-09-3026,380,101shares273
2021-07-01 to 2021-09-3018,286,352shares92
2021-01-01 to 2021-09-309,445,862shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.49USD/shares92
2022-01-01 to 2022-09-30-1.41USD/shares273
2021-07-01 to 2021-09-30-0.47USD/shares92
2021-01-01 to 2021-09-30-2.41USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.49USD/shares92
2022-01-01 to 2022-09-30-1.41USD/shares273
2021-07-01 to 2021-09-30-0.47USD/shares92
2021-01-01 to 2021-09-30-2.41USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-09-301,310,067USD
At 2021-12-31807,223USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-09-303,016,283USD273
2021-01-01 to 2021-09-301,170,040USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-13,188,150USD92
2022-01-01 to 2022-09-30-37,759,861USD273
2021-07-01 to 2021-09-30-8,543,384USD92
2021-01-01 to 2021-09-30-22,770,314USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-09-30120,024,690USD
At 2021-12-31152,333,996USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-09-307,255,772USD
At 2021-12-315,633,826USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-09-302,338,380USD
At 2021-12-311,394,340USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2022-09-306,690,431USD
At 2021-12-316,701,726USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2022-09-30416,263USD
At 2021-12-31439,000USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-09-3070,180USD
At 2021-12-31246,040USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-07-01 to 2022-09-3013,207,187USD92
2022-01-01 to 2022-09-3037,918,236USD273
2021-07-01 to 2021-09-308,806,426USD92
2021-01-01 to 2021-09-3023,713,832USD273

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-3019,037USD92
2022-01-01 to 2022-09-30158,375USD273
2021-07-01 to 2021-09-30263,042USD92
2021-01-01 to 2021-09-30943,518USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2022-07-01 to 2022-09-3019,343USD92
2022-01-01 to 2022-09-30158,122USD273
2021-07-01 to 2021-09-30219,088USD92
2021-01-01 to 2021-09-30946,852USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-07-01 to 2022-09-309,363,838USD92
2022-01-01 to 2022-09-3026,395,355USD273
2021-07-01 to 2021-09-306,207,486USD92
2021-01-01 to 2021-09-3018,590,471USD273

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2022-09-3076,417,850USD
At 2021-12-3174,888,145USD
At 2021-09-30106,927,550USD
At 2020-12-3137,090,151USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-09-30218,550,665USD
At 2021-12-31215,276,186USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2022-09-30-142,473USD
At 2021-12-31-49,009USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-09-304,512,883USD
At 2021-12-315,324,198USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2022-09-304,851,347USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2022-09-301,654,623USD
At 2021-12-31981,442USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2022-09-30344,556USD
At 2021-12-31174,219USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2022-09-30737,293USD
At 2021-12-31102,129USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-09-304,564,136USD
At 2021-12-313,965,447USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-09-302,757,220USD
At 2021-12-312,888,608USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-12,805,242USD92
2022-01-01 to 2022-09-30-37,361,471USD273
2021-07-01 to 2021-09-30-8,538,824USD92
2021-01-01 to 2021-09-30-22,756,140USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-303,836,032USD92
2022-01-01 to 2022-09-3011,500,144USD273
2021-07-01 to 2021-09-302,598,940USD92
2021-01-01 to 2021-09-305,123,361USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2022-07-01 to 2022-09-3068,075USD92
2022-01-01 to 2022-09-30170,337USD273
2021-07-01 to 2021-09-3011,978USD92
2021-01-01 to 2021-09-3030,652USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2022-07-01 to 2022-09-307,317USD92
2022-01-01 to 2022-09-3022,737USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2022-07-01 to 2022-09-30120,835USD92
2022-01-01 to 2022-09-30-6,434USD273
2021-07-01 to 2021-09-30-8,089USD92
2021-01-01 to 2021-09-30-8,089USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2021-01-01 to 2021-09-30120,318,750USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2022-01-01 to 2022-09-30479,976USD273
2021-01-01 to 2021-09-3083,160USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-175,860USD273
2021-01-01 to 2021-09-30-28,735USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30944,040USD273
2021-01-01 to 2021-09-30314,616USD273

Inspect the source

Entity
Immuneering Corporation / CIK 0001790340
Captured
2026-09-21T17:31:54.565Z
SEC response SHA-256
281639ad4fe90ed26318515f90817e9a8ec522eefe3f2cd43bc924b56b74c43a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001790340.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))